Daily BriefsECM

Daily Brief ECM: Tekscend Photomask IPO: Market Leader with Strong Prospects Ahead and more

In today’s briefing:

  • Tekscend Photomask IPO: Market Leader with Strong Prospects Ahead
  • LG Electronics India IPO- Strained in Legal Heat
  • Aimedbio IPO Preview
  • Semi-Tech Group Pre-IPO Tearsheet
  • Verisure: Justified Small IPO Premium to Peers Reflects Quality and Growth Profile
  • FineToday Pre-IPO – Refiling Updates
  • Canara Robeco AMC Ltd Pre-IPO: Strong Topline Growth & Expanding Margins


Tekscend Photomask IPO: Market Leader with Strong Prospects Ahead

By Shifara Samsudeen, FCMA, CGMA

  • Established in 2022, Tekscend Photomask (429A JP)  (previously Toppan Photomask) is the world’s leading semiconductor photomask supplier, holding a global market share of 38.9%.
  • Tekscend provides a diverse portfolio of high-precision photomasks for semiconductors, displays, MEMS, and R&D, including cutting-edge EUV masks, leveraging its expertise in microfabrication.
  • The company is planning for a listing on TSE on 16th October and plans to raise proceeds of around US$800m through a combination of existing and new share issues.

LG Electronics India IPO- Strained in Legal Heat

By Nitin Mangal

  • LG Electronics India (123D IN) much awaited INR 116.1 bn IPO is set to open for subscription this week. It’s a complete OFS by the Korean Parent.
  • While LG is the market leader, there are huge litigation liabilities ~74% of net-worth which could pose a serious threat to the financials, with particular attention to AMP spends proceedings.
  • We also find it disturbing to note that the parent has taken out 175% of the free cash flows in FY23 and FY24 as interim dividends.

Aimedbio IPO Preview

By Douglas Kim

  • Aimedbio is getting ready to complete its IPO in KOSDAQ in November 2025. The IPO price range is from 9,000 won to 11,000 won per share.
  • According to the bankers’ IPO price range, the expected market cap after the IPO is from 599 billion won to 732 billion won.
  • Aimedbio has advanced multiple antibody-drug conjugates (ADC) candidates into preclinical and early clinical stages.

Semi-Tech Group Pre-IPO Tearsheet

By Nicholas Tan

  • Semi-Tech Group (1890554D CH) is looking to raise at least US$200m in its upcoming Hong Kong IPO. The deal will be run by Deutsche Bank, CICC and Guotai.
  • It is a leading provider of intelligent industrial software solutions in China.
  • With strong commercialization capabilities, ST is one of the few China-based advanced-industry intelligent manufacturing software companies to achieve profitability.

Verisure: Justified Small IPO Premium to Peers Reflects Quality and Growth Profile

By Juan Pedro Rodríguez Serrate

  • Verisure offers a resilient, recurring-revenue model with strong growth visibility and leading share in Europe’s underpenetrated home security market. 
  • IPO valuation implies a small, justified premium to security peers, reflecting superior margins, scalability, and customer stickiness.
  • Despite high leverage, Verisure’s predictable cash flow and market leadership support solid post-IPO trading potential.

FineToday Pre-IPO – Refiling Updates

By Sumeet Singh

  • FineToday Holdings (420A JP) (FT) is planning to raise around US$280m via selling a mix of primary and secondary shares.
  • FineToday (FT) is a beauty and personal care company in Asia offering a range of products, including hair care, skin care and body care products.
  • In our previous note, we had looked at its past performance. In this note, we will talk about the updates from its most recent filings.

Canara Robeco AMC Ltd Pre-IPO: Strong Topline Growth & Expanding Margins

By Hong Jie Seow

  • Canara Robeco AMC (570515Z IN) is looking to raise US$150m in its upcoming India IPO.
  • Canara Robeco has registered a CAGR of 34% and 33% in AUM and management fees, respectively, from FY22 to FY24. Profitability margins have also expanded steadily in the same period.
  • In this note, we look at the company’s past performance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars